ARAV

Aravive Stock Price

4.05
0.21 (5.47%)
Upgrade to Real-Time
Afterhours (Closed)
4.05

Low
3.63

52 Week Range

High
9.95

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
Aravive Inc ARAV NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.21 5.47% 4.05 18:30:19
Open Price Low Price High Price Close Price Prev Close
3.86 3.86 4.24 4.05 3.84
Bid Price Ask Price Spread News
3.95 4.05 0.10 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
695 87,470 $ 4.02 $ 351,365 - 3.63 - 9.95
Last Trade Time Type Quantity Stock Price Currency
16:00:02 3 $ 4.05 USD

Period:

Draw Mode:

Aravive Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 83.89M 20.71M 14.90M $ 5.69M $ - -1.94 -2.40
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 64.04k 18.40%

more financials information »

Aravive News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ARAV Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week3.934.243.773.9282,6910.123.05%
1 Month4.084.39953.774.0574,685-0.03-0.74%
3 Months5.26445.983.634.68147,088-1.21-23.07%
6 Months9.059.243.635.45366,413-5.00-55.25%
1 Year6.189.953.635.80269,890-2.13-34.47%
3 Years6.5229.603.077.66190,736-2.47-37.88%
5 Years6.5229.603.077.66190,736-2.47-37.88%

Aravive Description

Aravive Inc is a clinical-stage biotechnology company. It focuses on developing therapies that target important survival pathways for both solid tumors as well as hematologic malignancies. The company's lead candidate AVB-500 is developed as a targeted therapy against ovarian cancer.


Your Recent History
NASDAQ
ARAV
Aravive
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.